| GC47927-10mg |
|
— |
PB-22 N-(4-hydroxypentyl)-3-carboxyindole metabolite
|
0 |
C14H17NO3 |
|
|
|
| GC47927-5mg |
|
— |
PB-22 N-(4-hydroxypentyl)-3-carboxyindole metabolite
|
0 |
C14H17NO3 |
|
|
|
| GC47927-1mg |
|
— |
PB-22 N-(4-hydroxypentyl)-3-carboxyindole metabolite
|
0 |
C14H17NO3 |
|
|
|
| GC47926 |
|
— |
|
0 |
[13C]7H6O4 |
|
|
|
| GC47925-10mg |
|
— |
Pasireotide (aspartate) (trifluoroacetate salt)
|
0 |
C58H66N10O9.2C4H7NO4.XCF3COOH |
|
|
|
| GC47925-5mg |
|
— |
Pasireotide (aspartate) (trifluoroacetate salt)
|
0 |
C58H66N10O9.2C4H7NO4.XCF3COOH |
|
|
|
| GC47925-1mg |
|
— |
Pasireotide (aspartate) (trifluoroacetate salt)
|
0 |
C58H66N10O9.2C4H7NO4.XCF3COOH |
|
|
|
| GC47924-25mg |
|
110882-85-4 |
|
0 |
C83H88Cl2N8O29 |
|
|
|
| GC47924-10mg |
|
110882-85-4 |
|
0 |
C83H88Cl2N8O29 |
|
|
|
| GC47924-5mg |
|
110882-85-4 |
|
0 |
C83H88Cl2N8O29 |
|
|
|
| GC47924-1mg |
|
110882-85-4 |
|
0 |
C83H88Cl2N8O29 |
|
|
|
| GC47923-5mg |
|
117490-41-2 |
|
0 |
C7H2D6N4O2 |
|
|
|
| GC47923-1mg |
|
117490-41-2 |
|
0 |
C7H2D6N4O2 |
|
|
|
| GC47923-500μg |
|
117490-41-2 |
|
0 |
C7H2D6N4O2 |
|
|
|
| GC47913-5mg |
|
— |
para-methyl AP-237 (hydrochloride)
|
0 |
C18H26N2O.HCl |
|
|
|
| GC47913-1mg |
|
— |
para-methyl AP-237 (hydrochloride)
|
0 |
C18H26N2O.HCl |
|
|
|
| GC47871-1mg |
|
179308-49-7 |
|
0 |
C11H14O5 |
|
|
|
| GC47870-25mg |
|
902614-04-4 |
Pantothenate Kinase Inhibitor
|
0 |
C21H21N5OS |
|
|
|
| GC47870-10mg |
|
902614-04-4 |
Pantothenate Kinase Inhibitor
|
0 |
C21H21N5OS |
|
|
|
| GC47870-5mg |
|
902614-04-4 |
Pantothenate Kinase Inhibitor
|
0 |
C21H21N5OS |
|
|
|
